Table 3.

Six-month stunting and wasting among live born infants by treatment group and vaccine impact on wasting and stunting by birth outcomes and cohorts.

		Wasting	Stunting
Z-score < −2	N	%	%
Placebo	1250	10.3	14.8
Vaccine	1276	11.0	13.6
		RR (95% CI)	RR (95% CI)
		1.06 (0.85, 1.33)	0.92 (0.76, 1.12)
LBW	484	1.24 (0.84, 1.83)	0.91 (0.68, 1.21)
Non-LBW	1545	1.04 (0.76, 1.44)	0.92 (0.67, 1.24)
Preterm	303	1.38 (0.77, 2.48)	0.92 (0.62, 1.36)
Term	2218	1.04 (0.81, 1.32)	0.95 (0.76, 1.18)
SGA	704	1.18 (0.84, 1.64)	1.03 (0.77, 1.38)
AGA	1233	1.09 (0.75, 1.58)	0.71 (0.51, 0.99)
Cohort 1	1528	1.34 (1.01, 1.78)	0.82 (0.62, 1.08)
Cohort 2	998	0.66 (0.44, 0.99)	1.06 (0.81, 1.38)
Z-score < −3	N	%	%
Placebo	1250	3.8	3.2
Vaccine	1276	2.6	2.0
		RR (95% CI)	RR (95% CI)
		0.69 (0.44, 1.07)	0.64 (0.39, 1.04)
LBW	484	1.24 (0.84, 1.83)	0.67 (0.35, 1.28)
Non-LBW	1545	1.04 (0.76, 1.44)	0.71 (0.25, 2.02)
Preterm	303	1.38 (0.77, 2.48)	0.61 (0.23, 1.64)
Term	2218	1.04 (0.81, 1.32)	0.67 (0.38, 1.18)
SGA	704	0.90 (0.51, 1.60)	0.66 (0.32, 1.35)
AGA	1233	0.69 (0.031, 1.54)	0.53 (0.20, 1.41)
Cohort 1	1528	0.79 (0.48, 1.32)	0.62 (0.32, 1.17)
Cohort 2	998	0.45 (0.19, 1.09)	0.67 (0.32, 1.41)